Applied Therapeutics logo

Applied Therapeutics Share Price (NASDAQ: APLT)

$0.5

-0.01

(-1.96%)

Last updated on

Check the interactive Applied Therapeutics Stock chart to analyse performance

Applied Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.49
    Today's High:$0.51

    Day's Volatility :4.46%

  • 52 Weeks Low:$0.30
    52 Weeks High:$10.62

    52 Weeks Volatility :97.22%

Applied Therapeutics Stock Returns

PeriodApplied Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
39.73%
3.6%
0.0%
6 Months
8.39%
-7.7%
0.0%
1 Year
-91.51%
-12.6%
0.0%
3 Years
-64.98%
9.5%
-4.7%

Applied Therapeutics Inc Key Stats

Check Applied Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.51
Open
$0.504
Today's High
$0.5137
Today's Low
$0.4908
Market Capitalization
$73.6M
Today's Volume
$503.2K
52 Week High
$10.6237
52 Week Low
$0.295
Revenue TTM
$121.0K
EBITDA
$-111.4M
Earnings Per Share (EPS)
$-0.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-150.82%

Stock Returns calculator for Applied Therapeutics Stock including INR - Dollar returns

The Applied Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Applied Therapeutics investment value today

Current value as on today

₹13,817

Returns

₹86,183

(-86.18%)

Returns from Applied Therapeutics Stock

₹91,468 (-91.47%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Applied Therapeutics Stock

-44%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Applied Therapeutics Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Applied Therapeutics Inc

  • Name

    Holdings %

  • T. Rowe Price Investment Management,Inc.

    13.16%

  • Vestal Point Capital LP

    8.10%

  • Propel Bio Management LLC

    7.95%

  • BlackRock Inc

    6.73%

  • Knoll Capital Management LP

    5.50%

  • Vanguard Group Inc

    3.34%

Analyst Recommendation on Applied Therapeutics Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Applied Therapeutics(by analysts ranked 0 to 5 stars)

Applied Therapeutics Share Price Target

What analysts predicted

Upside of 533.34%

Target:

$3.17

Current:

$0.50

Applied Therapeutics share price target is $3.17, a slight Upside of 533.34% compared to current price of $0.50 as per analysts' prediction.

Applied Therapeutics Stock Insights

  • Price Movement

    In the last 1 year, APLT stock has moved down by -92.2%
  • APLT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 162.1%
  • APLT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 178.5%
  • Price to Sales

    ForAPLT every $1 of sales, investors are willing to pay $497.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Applied Therapeutics Technicals Summary

Sell

Neutral

Buy

Applied Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Applied Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Applied Therapeutics Inc logo
12.84%
8.39%
-91.51%
-64.98%
-97.59%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Applied Therapeutics Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Organization
Applied Therapeutics
Employees
32
CEO
Mr. Les D. Funtleyder
Industry
Biotechnology

Key Management of Applied Therapeutics Inc

NameTitle
Mr. John H. Johnson
Executive Chairman
Mr. Les D. Funtleyder
Interm CEO, CFO, Principal Financial Officer & Director
Mr. Corwin Dale Hooks
Chief Commercial Officer
Mr. Constantine Chinoporos
COO & Chief Business Officer
Ms. Catherine Thorpe
Interim Chief Accounting Officer
Ms. Reena Thomas Colacot
Head of Quality
Dr. Todd F. Baumgartner M.D., M.P.H.
Chief Regulatory Officer
Dr. Evan Prescott Bailey M.D.
Chief Medical Officer
Ms. Dottie Caplan
Executive Vice President of Patient Advocacy & Government Affairs.

Important FAQs about investing in APLT Stock from India :

What is Applied Therapeutics share price today?

Applied Therapeutics share price today is $0.50 as on at the close of the market. Applied Therapeutics share today touched a day high of $0.51 and a low of $0.49.

What is the 52 week high and 52 week low for Applied Therapeutics share?

Applied Therapeutics share touched a 52 week high of $10.62 and a 52 week low of $0.30. Applied Therapeutics stock price today i.e. is closed at $0.50, lower by 95.29% versus the 52 week high.

How to invest in Applied Therapeutics Stock (APLT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Applied Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Applied Therapeutics Shares that will get you 3.0000 shares as per Applied Therapeutics share price of $0.50 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Applied Therapeutics Stock (APLT) from India?

Indian investors can start investing in Applied Therapeutics (APLT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Applied Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Applied Therapeutics share’s latest price of $0.50 as on August 30, 2025 at 1:29 am IST, you will get 20.0000 shares of Applied Therapeutics. Learn more about fractional shares .

What are the returns that Applied Therapeutics has given to Indian investors in the last 5 years?

Applied Therapeutics stock has given -97.59% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?